MetaCap

Sanofi ADS (SNY)

NASDAQ: SNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

40.20+0.64 (+1.62%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Pre-market: 40.08 -0.30%

SNY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$96.32B
P/E (TTM)
21.16
Forward P/E
7.44
EPS (TTM)
$1.90
Dividend yield
10.25% ($4.12)
Ex-dividend date
May 4, 2026
52-week range
39.18 – 52.68
Day range
39.73 – 40.25
Volume / Avg
2.08M / 2.89M
Beta
—
Shares outstanding
2.40B
Next earnings
Oct 30, 2026

52-week range

$39.18$52.68

SNY stock today

On Oct 7, SNY ended the session at $40.20, adding $0.64 (1.62%), versus the S&P 500's 0.22% decline. At this level, SNY sits near the bottom of its 52-week range of $39.18 to $52.68: 23.7% below the high, set on Nov 13, 2025 and 2.6% above the low. SNY is down 17.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 18.3%.

At 21.2x trailing earnings, Sanofi trades below the peer-group median of 29.4x. Its forward P/E of 7.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Sanofi's next earnings report is expected on Oct 30, 2026. Sanofi pays an annual dividend of $4.12 per share, a 10.25% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Sanofi

Company profile

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Ms. Belen Garijo Lopez M.D.
Headquarters
Paris
Employees
74,846
Website
sanofi.com

Analyst forecast

Forecast

Consensus (10 analysts)

buy

Avg. price target

$53.61+33.36%

  • Strong buy 0
  • Buy 5
  • Hold 5
  • Sell 0
  • Strong sell 0

Target range

Low $44.00High $63.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 30, 2026
EPS estimate
$1.72

Dividends

Dividend history
Annual dividend
$4.12
Dividend yield
10.25%
Last payment
$2.42
Ex-dividend date
May 4, 2026

SNY news

All SNY news

Sanofi peers

Health Care sector
SNY peer companies
CompanyPrice% ChgMarket capCompare
REGNRegeneron Pharmaceuticals Inc.742.12+0.46%$76.40Bvs SNY
BMYBristol-Myers Squibb Company59.70+0.18%$121.95Bvs SNY
VRTXVertex Pharmaceuticals Incorporated505.64+0.66%$128.16Bvs SNY
ONCBeOne Medicines Ltd. ADR364.02+0.34%$41.41Bvs SNY
RPRXRoyalty Pharma plc Class A56.76+0.57%$32.80Bvs SNY
ALNYAlnylam Pharmaceuticals Inc.224.41+0.21%$30.03Bvs SNY
ZTSZoetis Inc. Class A71.55+0.31%$29.57Bvs SNY
ROIVRoivant Sciences Ltd.34.75-2.20%$25.10Bvs SNY

Indexes, lists and sector

Appears in lists

Sanofi stock FAQ

What is Sanofi's stock price today?

SNY last traded at $40.20 as of Oct 7, 4:00 PM EDT, up 1.62% on the day. Prices are delayed at least 15 minutes.

Does Sanofi pay a dividend?

Yes. Sanofi pays $4.12 per share annually, a 10.25% yield. The most recent dividend of $2.42 had an ex-dividend date of May 4, 2026.

When is Sanofi's next earnings date?

Sanofi is expected to report earnings on Friday, October 30, 2026. Analysts expect EPS of $1.72.

What is SNY's P/E ratio?

SNY trades at a trailing P/E ratio of 21.16 and a forward P/E of 7.44, compared with a median of 29.4 for its closest peers.

Who is Sanofi's CEO?

Ms. Belen Garijo Lopez M.D. is the chief executive officer of Sanofi ADS, which has about 74,846 employees.

What is the SNY 52-week high?

The 52-week high for SNY is $52.68 and the 52-week low is $39.18. The stock is currently 23.7% below its high.

Compare SNY